The Comorbidity Burden: Unlocking Secondary Value in the HS Market

added blog Health

2025-12-26 09:47:23 -

Why should HS stakeholders care about metabolic syndrome and depression? HS is rarely a standalone condition. It is deeply linked to obesity, diabetes, PCOS, and significant mental health disorders. For pharmaceutical firms, this means that a drug that shows "collateral benefits"—such as improving metabolic markers or reducing systemic inflammation that contributes to cardiovascular...

0 Comments 0 Shares 237 Views 0 Reviews